chameleonseye PayPal Holdings ( PYPL ) named Alyssa Henry , the former CEO of Block's ( XYZ ) Square business, to its board as another director chose not to stand for re-election, the company said on Wednesday. Henry brings more than three decades of experience scaling global commerce, payments, and technology platforms to the board, the company said. The change comes as PayPal ( PYPL ) strives to...
chameleonseye PayPal Holdings ( PYPL ) named Alyssa Henry , the former CEO of Block's ( XYZ ) Square business, to its board as another director chose not to stand for re-election, the company said on Wednesday. Henry brings more than three decades of experience scaling global commerce, payments, and technology platforms to the board, the company said. The change comes as PayPal ( PYPL ) strives to accelerate its growth plan after Alex Chriss was ousted as CEO because his plan didn't progress quickly enough. "Her expertise in software-driven merchant solutions, omnichannel payments, and global platform expansion will be invaluable as we strengthen our position as a strategic payments partner to merchants and consumers worldwide," said PayPal President and CEO Enrique Lore. Gail J. McGovern, who has served on PayPal's ( PYPL ) board since 2015, will not stand for re-election at the company's annual stockholders meeting in May. Independent Director Ann Sarnoff will succeed McGovern as chair of the Corporate Governance and Nominating Committee of the board after the annual meeting. With Henry's appointment, the board consists of 12 directors, 11 of whom are independent. PayPal ( PYPL ) stock rose 1.3% in premarket trading. More on PayPal PayPal: Mr. Market Is Ignoring Just How Cheap It Is PayPal: The Great Algorithmic Mistake And The Valuation Paradox With A P/E Of 8 PayPal: Not Broken Enough To Sell Venmo users can send/receive payments from PayPal users Mastercard recruits 85 partners to new crypto program, including Circle, PayPal
Earlier this month Honda decided to cancel a trio of electric vehicles it was planning to build in the US. And those cancellations are having a ripple effect. Today Sony Honda Mobility—the automaker's joint venture with the electronics and entertainment company—announced that it won't bring its EVs to market either. Although Honda was an early adopter of hybrid technology, it has been left badly l...
Earlier this month Honda decided to cancel a trio of electric vehicles it was planning to build in the US. And those cancellations are having a ripple effect. Today Sony Honda Mobility—the automaker's joint venture with the electronics and entertainment company—announced that it won't bring its EVs to market either. Although Honda was an early adopter of hybrid technology, it has been left badly lagging when it comes to developing battery-electric cars. The diminutive Honda e might look like the most adorable city car you've ever seen , but it struggled to find more than 12,000 buyers in four years across Europe and Japan. Here in North America, the Prologue has done much better: Honda sold 33,000 in 2024, and another 39,000 last year. But the rebadged GM, which shares a platform with the Chevrolet Blazer, has seen sales implode since the end of the federal clean vehicle tax credit last fall, and it, too, leaves production at the end of the year. An earlier plan to use GM's battery platform for lower-cost EVs, meant to arrive in 2027 , died in late 2023 . Read full article Comments
Grandbrothers/iStock Editorial via Getty Images Denali Therapeutics ( DNLI ) added ~9% in the premarket on Wednesday after the U.S. Food and Drug Administration (FDA) approved its lead candidate, tividenofusp alfa, as a treatment for Hunter syndrome, a rare genetic disease. According to a federal database on drug approvals, the FDA approved tividenofusp alfa on Mar. 24 under the brand name Avlayah...
Grandbrothers/iStock Editorial via Getty Images Denali Therapeutics ( DNLI ) added ~9% in the premarket on Wednesday after the U.S. Food and Drug Administration (FDA) approved its lead candidate, tividenofusp alfa, as a treatment for Hunter syndrome, a rare genetic disease. According to a federal database on drug approvals, the FDA approved tividenofusp alfa on Mar. 24 under the brand name Avlayah. Also known as mucopolysaccharidosis type II (MPS II), Hunter syndrome represents a major unmet medical need, as current standard-of-care enzyme replacement therapies are unable to address the neurological symptoms of the disease. In December, Denali ( DNLI ) reached an agreement with Royalty Pharma ( RPRX ) to receive $275M in funding in exchange for a 9.25% royalty on global net sales of tividenofusp alfa. At the time, its Biologics License Application for the treatment, also known as DNL310, was under FDA review, with a decision on a potential accelerated approval expected on or before Apr. 5. More on Denali Therapeutics Denali Therapeutics Inc. (DNLI) Presents at Stifel 2026 Virtual CNS Forum Transcript Denali Therapeutics Inc. (DNLI) Presents at Leerink Global Healthcare Conference 2026 Transcript Denali Therapeutics Inc. (DNLI) Presents at TD Cowen 46th Annual Health Care Conference Transcript Seeking Alpha’s Quant Rating on Denali Therapeutics Historical earnings data for Denali Therapeutics
Olga Yastremska/iStock via Getty Images Spice maker McCormick & Company ( MKC ) doesn’t seem to be in favor with investors. I, however, continue to believe the negative sentiment presents an attractive opportunity for those seeking selective positioning for the long term. Over the past year, shares are down 35%, including an over 20% decline YTD. I last covered MKC following its release of its Q4 ...
Olga Yastremska/iStock via Getty Images Spice maker McCormick & Company ( MKC ) doesn’t seem to be in favor with investors. I, however, continue to believe the negative sentiment presents an attractive opportunity for those seeking selective positioning for the long term. Over the past year, shares are down 35%, including an over 20% decline YTD. I last covered MKC following its release of its Q4 results in late January, and shares are down 14% since that update. This compares to a decline of 5% in the broader S&P ( SPY ) over the same period. Seeking Alpha - 1-YR Shares Price Returns Of MKC Stock In March, Unilever ( UL ) put out a presser that it received an offer for its food business from MKC and that discussions are ongoing. I believe this is an interesting development and could certainly see it being a topic of discussion at the upcoming Q1 release. Ahead of the release, I maintain a bullish view on MKC and continue to see it as a value-add for a consumer staple that I believe still has positive demand fundamentals. MKC Key Stock Metrics At the time of my last publication, MKC was trading at a forward of 22x earnings . Today, shares are even more attractively priced at 16.8x. This is nearly 40% below MKC’s five-year averages. Even on other measures, MKC looks competitively priced. Its enterprise value to sales, for example, stands at just 2.7x compared to the historical average of about 4x. Seeking Alpha - Valuation Metrics Of MKC Stock Consensus targets still see MKC valued appropriately at about the $70/share mark, and I certainly believe MKC can regain this territory. Seeking Alpha - Average Price Target Of MKC Stock At today’s prices, expectations seem awfully low for performance, and I believe this could set up a nice rebound in the share price in the event of any better-than-expected performance. What Is The Outlook for MKC Stock? I continue to view MKC’s forward outlook as relatively solid, especially when you separate near-term noise from underlying fu...
Founder Group ( FGL ) on Wednesday said, in collaboration with a prominent solar investment company, it has secured an EPC contract valued at RM34 million (approximately $8.6M) under Malaysia’s Large Scale Solar 5 (“LSS5”) program. As per the newly signed contract, Founder Group will undertake the design, construction, testing, and commissioning of the 9.5 MW solar facility the company agreed to b...
Founder Group ( FGL ) on Wednesday said, in collaboration with a prominent solar investment company, it has secured an EPC contract valued at RM34 million (approximately $8.6M) under Malaysia’s Large Scale Solar 5 (“LSS5”) program. As per the newly signed contract, Founder Group will undertake the design, construction, testing, and commissioning of the 9.5 MW solar facility the company agreed to build under LSS5 earlier this month. That facility is scheduled to achieve commercial operation not later than May 1, 2027. FGL -7.22% premarket to $4.11. Source: Press Release More on Founder Group Limited Founder Group secures $5 million EPC contract for 5.5MW solar plant Founder Group secures 25.4MW utility-scale solar contract worth $4.14M Financial information for Founder Group Limited
Visteon (NASDAQ:VC) CEO and President Sachin Lawande exercised 49,453 employee stock options and immediately sold the resulting shares on March 4, 2026, for a total of roughly $4.62 million, according to an SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($93.44); post-transaction value based on March 24, 2026, market close ($86.00). *A subsequent Form 4 f...
Visteon (NASDAQ:VC) CEO and President Sachin Lawande exercised 49,453 employee stock options and immediately sold the resulting shares on March 4, 2026, for a total of roughly $4.62 million, according to an SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($93.44); post-transaction value based on March 24, 2026, market close ($86.00). *A subsequent Form 4 filed March 17, 2026, reflects routine RSU vesting and related tax withholding on March 15, 2026, bringing Lawande's direct share count to approximately 193,822. That filing involved no discretionary selling and is separate from the transaction described here. Continue reading
More on Paychex Paychex: If Shares Keep Falling, An Upgrade Could Be In Store Paychex: Mind The Margin With A Moat Clocking Out Paychex: A Deal Too Good To Pass Up Paychex beats top-line and bottom-line estimates; updates FY26 outlook Paychex Q3 2026 Earnings Preview
More on Paychex Paychex: If Shares Keep Falling, An Upgrade Could Be In Store Paychex: Mind The Margin With A Moat Clocking Out Paychex: A Deal Too Good To Pass Up Paychex beats top-line and bottom-line estimates; updates FY26 outlook Paychex Q3 2026 Earnings Preview
Everyone knows that war in Iran is curbing the flow of oil around the world. But the commodity is also a crucial feedstock for petrochemicals, including the building blocks of a variety of plastics. On this episode of the Odd Lots podcast, Joe Weisenthal and Tracy Alloway discuss what a petrochemical supply chain disruption means for the future of plastics and packaging. (Source: Bloomberg)
Everyone knows that war in Iran is curbing the flow of oil around the world. But the commodity is also a crucial feedstock for petrochemicals, including the building blocks of a variety of plastics. On this episode of the Odd Lots podcast, Joe Weisenthal and Tracy Alloway discuss what a petrochemical supply chain disruption means for the future of plastics and packaging. (Source: Bloomberg)
Mojtaba Khamenei visits Hezbollah's office in Tehran, Iran, October 1, 2024. Office Of The Iranian Supreme Le | Via Reuters Iran will not accept a ceasefire offer from the United States , Iranian state media reported Wednesday. The FARS News Agency state media outlet, citing what it called an informed source, said there have been increased U.S. efforts to put a ceasefire into effect and start indi...
Mojtaba Khamenei visits Hezbollah's office in Tehran, Iran, October 1, 2024. Office Of The Iranian Supreme Le | Via Reuters Iran will not accept a ceasefire offer from the United States , Iranian state media reported Wednesday. The FARS News Agency state media outlet, citing what it called an informed source, said there have been increased U.S. efforts to put a ceasefire into effect and start indirect talks with Iran to end the war that began on Feb. 28 with strikes by the U.S. and Israel on the Islamic Republic. "Iran does not accept a ceasefire," that source told FARS, according to a translation of the news site's Telegram page t hat reported the interview. "Basically, it is not logical to enter into such a process with those who violate the agreement," the source said. The source also told Fars that Iran intends to realize its strategic goals in the war, and that only when that happens will there be a possibility of ending the conflict, the outlet reported. Read more U.S.-Iran war news Trump tells CNBC 'we are very intent on making a deal' with Iran Oil tumbles after Trump postpones U.S. strikes against Iran energy infrastructure for five days European stocks stage rebound as Trump signals Iran war de-escalation Gold and silver pare losses as Trump postpones strikes More than 40 Middle East energy assets 'severely damaged,' IEA chief says Saudi Aramco boss pulls out of major international energy conference due to Iran conflict: Reuters Trump and Tehran issue dueling warnings on the Strait of Hormuz Iran threatens U.S. Treasury buyers as Trump's 48-hour ultimatum looms U.K. confirms Iran fired two missiles at British-American base in Indian Ocean U.S. allows 30-day sale of Iran oil at sea in bid to tame prices Trump: Don't want Iran war ceasefire, considering 'winding down' military Trump: U.S. could end Iran war but will continue so it can 'never rebuild' Netanyahu: Iran 'decimated' but revolution requires 'ground component' Trump invokes Pearl Harbor in front of...